LATS1 and neoplasm: Based on this finding, a SuperHippo peptide covering the WWC1/2/3-LATS1/2 interaction interface was thus developed to robustly activate LATS1/2 kinase activity, demonstrating excellent tumor suppression effects in multiple tumor models[123].